These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Shift shown in influenza A adamantane resistance. Shea KM JAMA; 2006 Oct; 296(13):1585; author reply 1586-7. PubMed ID: 17018800 [No Abstract] [Full Text] [Related]
3. Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern? Ansaldi F; Valle L; Amicizia D; Banfi F; Pastorino B; Sticchi L; Icardi G; Gasparini R; Crovari P J Prev Med Hyg; 2006 Mar; 47(1):1-3. PubMed ID: 17061402 [No Abstract] [Full Text] [Related]
4. Update on influenza vaccination for the 2005-2006 season. An Advisory Committee Statement (ACS). Advisory Committee On Immunization (NACI) Can Commun Dis Rep; 2006 Mar; 32(ACS-2):1-3. PubMed ID: 16710946 [No Abstract] [Full Text] [Related]
5. Recommended composition of influenza virus vaccines for use in the 2010 influenza season (southern hemisphere winter). Wkly Epidemiol Rec; 2009 Oct; 84(41):421-31. PubMed ID: 19817019 [No Abstract] [Full Text] [Related]
6. Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec; 2008 Oct; 83(41):366-72. PubMed ID: 18846716 [No Abstract] [Full Text] [Related]
7. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec; 2014 Mar; 89(10):93-104. PubMed ID: 24707514 [No Abstract] [Full Text] [Related]
8. Adamantane resistance in influenza A. Weinstock DM; Zuccotti G JAMA; 2006 Feb; 295(8):934-6. PubMed ID: 16493107 [No Abstract] [Full Text] [Related]
9. [Review of materials of VI International Conference "Options for the Control for Influenza"]. Nekrasov AV; Puchkova NG Zh Mikrobiol Epidemiol Immunobiol; 2008; (3):115-20. PubMed ID: 18595477 [No Abstract] [Full Text] [Related]
10. Neuraminidase inhibitors for influenza. Moscona A N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481 [No Abstract] [Full Text] [Related]
11. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Barr IG; Deng YM; Iannello P; Hurt AC; Komadina N Antiviral Res; 2008 Nov; 80(2):200-5. PubMed ID: 18611414 [TBL] [Abstract][Full Text] [Related]
12. Antiviral drugs for influenza. Med Lett Drugs Ther; 2007 Oct; 49(1272):85-6. PubMed ID: 17938610 [No Abstract] [Full Text] [Related]
13. Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season. Wkly Epidemiol Rec; 2012 Mar; 87(10):83-95. PubMed ID: 22462202 [No Abstract] [Full Text] [Related]
14. Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. Wkly Epidemiol Rec; 2012 Oct; 87(41):389-400. PubMed ID: 23074737 [No Abstract] [Full Text] [Related]
15. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859 [TBL] [Abstract][Full Text] [Related]
16. [Prevention of influenza]. Bricaire F Rev Prat; 1979 May; 29(27):2237-47. PubMed ID: 94691 [No Abstract] [Full Text] [Related]
17. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Wkly Epidemiol Rec; 2011 Mar; 86(10):86-90. PubMed ID: 21395187 [No Abstract] [Full Text] [Related]
18. Shift shown in influenza A adamantane resistance. Shah RC JAMA; 2006 Oct; 296(13):1585-6; author reply 1586-7. PubMed ID: 17018799 [No Abstract] [Full Text] [Related]